188 participants
An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-13
- Start Date:
- 2023-11-01
- Completion:
- 2024-11-04
Conditions
- Thyroid Eye Disease
Interventions
- DRUG